KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Edwards Lifesciences (EW) Other Gross PP&E Adjustments (2019 - 2025)

Edwards Lifesciences (EW) has 13 years of Other Gross PP&E Adjustments data on record, last reported at $789.5 million in Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments rose 10.4% year-over-year to $789.5 million; the TTM value through Dec 2025 reached $789.5 million, up 10.4%, while the annual FY2025 figure was $789.5 million, 10.4% up from the prior year.
  • Other Gross PP&E Adjustments reached $789.5 million in Q4 2025 per EW's latest filing, up from -$96.5 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $789.5 million in Q4 2025 and bottomed at -$104.4 million in Q3 2024.
  • Average Other Gross PP&E Adjustments over 5 years is $2.7 million, with a median of -$89.3 million recorded in 2021.
  • Peak YoY movement for Other Gross PP&E Adjustments: dropped 17.22% in 2021, then surged 580.4% in 2024.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at -$92.1 million in 2021, then dropped by 0.22% to -$92.3 million in 2022, then skyrocketed by 213.87% to $105.1 million in 2023, then soared by 580.4% to $715.1 million in 2024, then rose by 10.4% to $789.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Gross PP&E Adjustments were $789.5 million in Q4 2025, -$96.5 million in Q3 2025, and -$99.0 million in Q2 2025.